Haemoglobin A1c (HbA1C) in Non-diabetic and Diabetic Vascular Patients. Is HbA1C an Independent Risk Factor and Predictor of Adverse Outcome?

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 2, 2006, Pages 188-197

  O'Sullivan, C J ^a,b   Hynes, N ^a,b   Mahendran, B ^a,b   Andrews, E J ^a,b   Avalos, G ^a,b   Tawfik, S ^a,b   Lowery, A ^a,b   Sultan, S ^a,b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b Galway Clinic   (Ireland)

Author keywords

Diabetes mellitus; Haemoglobin A1c; HbA1C; Morbidity; Postoperative; Risk factors; Vascular surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETIC ANGIOPATHY; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE; SURGICAL INFECTION; SURGICAL MORTALITY; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 33748776607     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.01.011     Document Type: Article

References (35)

1. Krishnamurti U., and Steffes M.W. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem 47 7 (2001) 1157-1165
2. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., and Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141 6 (2004) 413-420
3. Barr R.G., Nathan D.M., Meigs J.B., and Singer D.E. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137 4 (2002) 263-272
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
5. UK Prospective Diabetes Study Group. Intensive blood group with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
6. Corpus R.A., O'Neill W.W., Dixon S.R., Timmis G.C., and Devlin W.H. Relation of hemoglobin A1c to rate of major adverse cardiac events in patients without diabetes undergoing percutaneous coronary revascularization. Am J Cardiol 92 (2003) 1282-1286
7. Medhi M., Marshall Jr. M.C., Burke H.B., Hasan R., Nayak D., Reed G., et al. HbA1c predicts length of stay in patients admitted for coronary artery bypass surgery. Heart Dis 3 (2001) 77-79
8. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycosylated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322 (2001) 1-6
9. Gerstein H.C. Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor. Ann Intern Med 141 6 (2004) 475-476
10. Park S., Barrett-Connor E., Wingard D.L., Shan J., and Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 19 5 (1996) 450-456
11. Jorgensen L., Jenssen T., Joakimsen O., Heuch I., Ingebretsen O.C., and Jacobsen B.K. Glycosylated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromso study. Circulation 110 4 (2004) 466-470
12. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 2 (1999) 233-240
13. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes care 28 (2005) S37-S42
14. Vitelli L.L., Shahar E., Heiss G., McGovern P.G., Brancati F.L., Eckfeldt J.H., et al. Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study. Diabetes Care 20 9 (1997) 1454-1458
15. Kilpatrick A.A. Glycated haemoglobin in the year 2000. J Clin Pathol 53 (2000) 335-339
16. American Diabetes Association. Standards of care for patients with diabetes mellitus. Diabetes Care 25 Suppl. 1 (2002) S33-S49
17. Brownlee M. Glycation and diabetic complications. Diabetes 43 (1994) 836-841
18. Gernstein H.C. Glucose: a continuous risk factor for cardiovascular disease. Diabet Med 14 (1997) S25-S31
19. Fisman E.Z., Motro M., Tenenbaum A., Boyko V., Mandelzweig L., and Behar S. Impaired fasting glucose concentrations in nonpatients with diabetes with ischemic heart disease: a marker for a worse prognosis. Am Heart J 141 (2001) 485-490
20. Scheidt-Nave C., Barrett-Connor E., and Eingard D. Sex differences in fasting glycemia as a risk factor for ischemic heart disease. Am J Epidemiol 133 (1991) 565-576
21. Simons L., Friedlander Y., and McCallum J. Fasting plasma glucose in non-diabetic elderly women predicts increased all-cause mortality and coronary heart disease risk. Aust N Z J Med 30 (2000) 41-47
22. Yarnell J., Pickering J., and Elwood P. Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 47 (1994) 383-388
23. Hu G., Qiao Q., and Tuomilehto J. Glucose tolerance and cardiovascular mortality. Cardiovasc Rev Rep 22 (2001) 649-654
24. Hanefeld M., Fischer S., and Julius U. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11 year follow-up. Diabetologia 39 (1996) 1577-1583
25. Shah J., and Hodge A. Isolated post-challenge hyperglycemia confirmed as a risk factor for mortality. Diabetologia 42 (1999) 1050-1054
26. Tominaga M., Eguchi H., and Manaka H. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Fungata Diabetes Study. Diabetes Care 22 (1999) 233-240
27. Briguori C., Condorelli G., Airoldi F., Mikhail G.W., Ricciardelli B., and Colombo A. Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in patients with diabetes. Heart 90 12 (2004) 1481-1482
28. Oaikhinan K., Hirpara K., Akhtar Y., Heskin L., Manning B., Aremu M., et al. An observational parallel group comparative study with and without the 'Magic Bullet' (MB: Aspirin, cardio selective beta-blocker, Pravastatin and Clopidogrel) in the peri-operative and postoperative period for abdominal aortic aneurysms surgery and femoral-popliteal segment revascularisation. Does the 'Magic Bullet' improve the 30-day morbidity and mortality outcome?. Br J Surg 91 1 (2004) 113-114
29. Thourani V.H., Weintraub W.S., Stein B., Gebhart S.S.P., Craver J.M., Jones E.L., et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 67 (1999) 1045-1052
30. Lauruschkat A.H., Arnrich B., Albert A.A., Walter J.A., Amann B., Rosendahl U.P., et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 112 (2005) 2397-2402
31. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation. Circulation 96 (1997) 1761-1769
32. Detre K.M., Lombardero M.S., Brooks M.M., Hardison R.M., Holubkov R., Sopko G., et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Engl J Med 342 (2000) 989-997
33. Niles N.W., McGrath P.D., Malenka D., Quinton H., Wennberg D., Shubrooks S.J., et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous revascularization: results of a large regional prospective study: Northern New England Cardiovascular Study Group. J Am Coll Cardiol 37 (2001) 1016-1018
34. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32 (1998) 584-589
35. Serruys P.W., Unger F., Sousa J.E., Jatene A., Bonnier H., Schönberger J., et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124